Newly-listed audiology specialist, Audeara Ltd (ASX:AUA), has reported a strong jump in revenue and clinical attendances for the first four months of CY 2021.
Revenues for the period was up 28%, while clinical attendances rose by 15%.
93 additional audio clinics have onboarded since the company’s recent listing, with audiology clinic revenue rising by 54%.
Managing Director and CEO, James Fielding, said the company continues to grow its presence in Australia, with sales momentum continuing to build in recent months.
On a constrained pre-IPO basis, Audeara has continued to grow in its core wholesale business into the audiology clinics. With funding now secured, I am excited to see what the business can now do as we commit resources into sales and marketing activities, as well as commence our expansion into the US,” Mr Fielding said.
Audeara Limited is a technology company that has developed a hearing profile algorithm used to personalise sound output to the needs of the individual.
The Company’s first product is the Audeara A01 headphone with accompanying BT01 Bluetooth transceiver. Audeara’s mobile application (the Audeara App) uses a proprietary personalisation algorithm and software interface to produce tailored audio for users of linked audio devices.
Audeara’s technology platform allows customers to enjoy sound personalised for their unique hearing profile, offering a superior sound experience while promoting the importance of their hearing health.
The Audeara A01 headphones are noise-cancelling consumer headphones that deliver high quality and personalised audio to users and are designed for use in mainstream applications, such as listening to music, streaming movies, and television, video chat and PC and console gaming.
